Cargando…
Analgesic characteristics of a newly developed α(2)δ ligand, mirogabalin, on inflammatory pain
Mirogabalin is a novel α(2)δ ligand approved in Japan for the treatment of peripheral neuropathic pain. However, the sites of action of α(2)δ ligands to produce analgesic effects on inflammatory pain remain unclear. In this study, we investigated the analgesic effect and site of action of mirogabali...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649095/ https://www.ncbi.nlm.nih.gov/pubmed/34823399 http://dx.doi.org/10.1177/17448069211052167 |